Company Filing History:
1 out of 2,623 
1 out of 291 
Years Active: 2014-2019
Title: Discovering Innovations in Neuroscience: The Contributions of Steven Brem
Introduction: Steven Brem, an esteemed inventor based in Haverford, PA, has made significant contributions to the field of neuroscience through his innovative research and patented technologies. With two patents to his name, Brem focuses on advancing diagnostic and therapeutic methodologies that offer new hope in the battle against high-grade gliomas.
Latest Patents: Brem's latest patents showcase his expertise in the medical domain. The first patent, titled "Edema invariant tractography," presents methods for acquiring data via multishell, high angular resolution diffusion imaging sequences. This methodology incorporates a multi-compartment model to facilitate accurate fiber reconstruction using a probabilistic tracking algorithm. The second patent, which relates to "Methods of predicting high-grade gliomas using senescence associated genes," identifies biomarkers linked to high-grade gliomas. This invention emphasizes the role of overexpression of senescence associated genes (SAG) in predicting therapy responses, diagnosing such neoplasias, and monitoring disease progression.
Career Highlights: Steven Brem has built a reputable career in research, having worked at renowned institutions such as the University of Pennsylvania and the H. Lee Moffitt Cancer Center and Research Institute. His work is not only limited to innovation but also includes a commitment to enhancing patient outcomes through scientific discovery.
Collaborations: Throughout his career, Brem has collaborated with notable professionals in his field, including Ragini Verma and Luke Macyszyn. These partnerships have further enriched his research endeavors, allowing for the sharing of insights and advancements in medical technology.
Conclusion: As a recognized inventor, Steven Brem's work continues to impact the field of neuroscience substantially. His patents reflect a deep commitment to improving diagnostic and treatment methodologies for high-grade gliomas, marking him as a significant figure in the realm of medical innovations.